|
|
 |
|
Viewing report
|
|
|
|
Generics in Europe
Datamonitor, Sep 2009, Pages: 32
The Generics in Europe industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.
Scope
- Contains an executive summary and data on value, volume and/or segmentation
- Provides textual analysis of the industry’s recent performance and future prospects
- Incorporates in-depth five forces competitive environment analysis and scorecards
- Includes a five-year forecast of the industry
- The leading companies are profiled with supporting key financial metrics
- Supported by the key macroeconomic and demographic data affecting the market
Highlights
- Detailed information is included on market size, measured by value and/or volume
- Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape
Why you should buy this report
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
Market Definition
The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. Datamonitor defines a generic as an officially-approved copy of an original product whose patent has expired, marketed either as a brand or using the generic name.
This definition excludes multi-source copy products, that make up much of markets such as India, Spain and Italy. Multi-source copies are drugs still under patent that are offered by manufacturers other than the patent holders. All currency conversions have been calculated at constant 2008 average exchange rates.
For the purpose of this report Europe is deemed to comprise of Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, the Ukraine and the United Kingdom.
The global figure is deemed to comprise of the Americas, Asia-Pacific and Europe.
The Americas comprises Argentina, Brazil, Canada, Chile, Colombia, Mexico, Venezuela, and the US.
Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.
Customers who bought this item also bought
Emerging Generic Pharmaceuticals Markets in Europe
Emerging Generic Drug Markets in Europe
The European Generics Outlook: A Country-By-Country Analysis Of Developing Market Opportunities And Revenue Defense Strategies
European Generic Drug Market Potential
The Outlook for Pharmaceuticals in Central & Eastern Europe to 2013
IMS Pharma Pricing & Reimbursement Concise Guide Series Central & Eastern Europe
The Challenges of Reference Pricing in Europe
European Endometriosis Therapeutics Market
European Animal Health Regulations (2 Volumes)
European Animal Health Markets & Opportunities
Pharmacy Liberalisation in Europe: Prospects and Implications
The Outlook for Pharmaceuticals in Northern Europe to 2013
|
|
|
|
